99% Tirzepatide Peptide GLP-1 5mg 10mg 15mg CAS 2023788-19-2 Safe Delivery for Weight Loss

Product Description:

Tirzepatide powder is the raw form of Tirzepatide, a synthetic peptide used primarily in the treatment of type 2 diabetes. It acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, enhancing insulin secretion and lowering blood sugar levels. Tirzepatide also slows gastric emptying and promotes weight loss, making it a valuable option for patients with diabetes and obesity. Typically, this powder is utilized in pharmaceutical manufacturing, where it is formulated into injectable medications for clinical use. Its innovative mechanism of action and efficacy in improving metabolic health represent significant advancements in diabetes management.

Technical Parameters:

Dosage:

The dosage of Tirzepatide for treating type 2 diabetes, typically follows a gradual titration to minimize side effects and optimize effectiveness. It is administered via subcutaneous injection once weekly.

Here’s a general dosing schedule:

1. Starting dose: 2.5 mg once a week for the first 4 weeks. This low dose helps the body adjust to the medication.
2. Dose escalation:
After 4 weeks at 2.5 mg, the dose is increased to 5 mg once weekly.
If further blood sugar control is needed, the dose may be increased in 2.5 mg increments every 4 weeks, up to a maximum dose of 15 mg per week.

Titration schedule:

Week 1–4: 2.5 mg weekly
Week 5–8: 5 mg weekly
After 8 weeks: Based on effectiveness and tolerance, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or 15 mg.

The dosage is tailored to the individual patient’s needs and response to the medication. Higher doses may offer additional benefits for glucose control and weight loss, but they also increase the likelihood of gastrointestinal side effects, such as nausea or diarrhea.

Patients should follow the dosage prescribed by their healthcare provider to ensure safety and efficacy.

Applications:

Tirzepatide is a novel medication with multiple functions, primarily used for the treatment of type 2 diabetes and showing potential for weight loss. Its main functions are:

1. Blood Glucose Regulation:

Tirzepatide acts as a dual agonist of GLP-1 (glucagon-like peptide-1) receptor and GIP (glucose-dependent insulinotropic polypeptide) receptor. By stimulating these two receptors, it enhances the body's natural production of insulin in response to elevated blood sugar, particularly after meals.
It also reduces the secretion of glucagon, a hormone that raises blood sugar levels, which helps to lower and stabilize glucose levels in the bloodstream.

2. Slows Gastric Emptying:

Tirzepatide delays the emptying of the stomach, leading to a slower release of glucose into the bloodstream. This helps prevent spikes in blood sugar after eating.

3. Weight Loss:

Because Tirzepatide targets both GLP-1 and GIP receptors, it has been found to promote significant weight loss in patients. It reduces appetite and increases satiety, making individuals feel fuller for longer periods, contributing to reduced food intake and weight management.

4. Cardiovascular Benefits:

The blood sugar-lowering effects of Tirzepatide, combined with its potential for weight reduction, also offer cardiovascular benefits by improving overall metabolic health, which may help reduce the risk of heart disease.

Overall, Tirzepatide provides an effective approach to improving blood sugar control in type 2 diabetes patients, while also promoting weight loss and improving other metabolic outcomes.

Packing and Shipping: